Watch on-demand as PrecisionLife CEO, Dr Steve Gardner, joins Cyclica CEO, Naheed Kurji, exploring Disease Mechanisms and Novel Target Discovery.
In this webinar, Steve and Naheed present the latest advances in genomics, the impact on drug target discovery, and how combinatorial analytics is being applied to finding new treatment approaches for patients with unmet medical needs in a wide range of chronic diseases.
See every episode in the Cyclica Molecule to Medicine series.